Market Place
Sourcing Support
Amgen Terminates Autoimmune Partnership With Kyowa Kirin
02 Feb 2026 //
BIOSPACE
Amgen Exits $400M Autoimmune Pact After Running Vast Program
30 Jan 2026 //
FIERCE BIOTECH
Amgen Announces Q4 and FY 2025 Results Webcast
28 Jan 2026 //
PR NEWSWIRE
Biocom Unveils Keynote Panel With Abbvie, Amgen, Eli Lilly Heads
21 Jan 2026 //
BUSINESSWIRE
Nonprofit Health Services Organization Sues Fortune 500 Pharma
20 Jan 2026 //
BUSINESSWIRE
AbbVie, Amgen, Lilly Urge FDA to Update Post-Approval Rules
13 Jan 2026 //
BIOSPACE
Amgen says MariTide Helped Trial Patients Maintain Weight Loss
13 Jan 2026 //
REUTERS
Amgen to Present at 44th J.P. Morgan Healthcare Conference
07 Jan 2026 //
PR NEWSWIRE
DISCO Pharma Licenses Novel Cancer Surfaceome Targeted Therapies
07 Jan 2026 //
GLOBENEWSWIRE
Dark Blue Therapeutics Acquired By Amgen For Up To $840 Million
06 Jan 2026 //
PR NEWSWIRE
Abbvie Counters Amgen, Invests $100M In Trispecific Lung Cancer
05 Jan 2026 //
BIOSPACE
Amgen Collaborates with U.S. Government to Reduce Drug Costs
20 Dec 2025 //
PR NEWSWIRE
FDA Approves Uplizna for Generalized Myasthenia Gravis in Adults
11 Dec 2025 //
PR NEWSWIRE
Amgen Announces 2026 First Quarter Dividend
10 Dec 2025 //
PR NEWSWIRE
Inductive Bio Secures $21M To Enhance AI Drug Toxicity Models
08 Dec 2025 //
PR NEWSWIRE
Amgen signs on as 2026 World Cup host city supporter in LA
08 Dec 2025 //
FIERCE PHARMA
LASEC Names Amgen Official Biotech Partner For FIFA World Cup
05 Dec 2025 //
PR NEWSWIRE
Biocon Biologics Settles With Amgen For Denosumab Biosimilars
02 Dec 2025 //
EXPRESSPHARMA
Avantor Wins 2025 Edison Patent Award For Viral Inactivation Tech
25 Nov 2025 //
PR NEWSWIRE
Amgen to Present at 8 Th Evercore ISI Healthconx Conference
24 Nov 2025 //
PR NEWSWIRE
Amgen to Present at Citi`s 2025 Global Healthcare Conference
24 Nov 2025 //
PR NEWSWIRE
Survey Shows `cardiology deserts` at Heart of Amgen-Backed Drive
14 Nov 2025 //
FIERCE PHARMA
ImmunoScape Advances Next-Gen Cell Therapy, Adds Key Leaders
13 Nov 2025 //
BUSINESSWIRE
Amgen Cholesterol Drug Cuts Risk of First Cardiac Event by 25%
08 Nov 2025 //
REUTERS
Amgen Boosts Confidence In US Biosimilar Market With 52% Sales
07 Nov 2025 //
INDPHARMAPOST
Amgen Stands Out In Obesity Market Amid Bidding War
05 Nov 2025 //
BIOSPACE
Amgen Halts Gastric Cancer Trial After Subpar Efficacy Analysis
05 Nov 2025 //
FIERCE BIOTECH
Amgen CEO Critiques FDA Push To Reform Biosimilars Market
05 Nov 2025 //
FIERCE PHARMA
Amgen Reports Third Quarter 2025 Financial Results
05 Nov 2025 //
PR NEWSWIRE
Italian Biotech Raises $141M Series B To Fund Eye Gene Therapies
04 Nov 2025 //
FIERCE BIOTECH
Amgen to Present Repatha Phase 3 Data at AHA Scientific Sessions
31 Oct 2025 //
PR NEWSWIRE
Amgen Announces 2025 Fourth Quarter Dividend
31 Oct 2025 //
PR NEWSWIRE
Amgen Announces Webcast of 2025 Third Quarter Financial Results
29 Oct 2025 //
PR NEWSWIRE
Tezspire Approved for Chronic Rhinosinusitis with Nasal Polyps
20 Oct 2025 //
PRESS RELEASE
Astrazeneca Strikes DTC Deal With Trump Administration
10 Oct 2025 //
BIOSPACE
Amgen Hops On DTC Train To Offer Repatha At 60% Discount
07 Oct 2025 //
BIOSPACE
AMGEN Launches REPATHA® DIRECT-TO-PATIENT PROGRAM IN U.S.
06 Oct 2025 //
PR NEWSWIRE
Amgen`s Phase III Data Supports FDA Label Expansion Of Repatha
05 Oct 2025 //
INDPHARMAPOST
Amgen Expands US Manufacturing Network With $650M Investment
26 Sep 2025 //
FIERCE PHARMA
Amgen Makes Portfolio Play Amid Scrutiny of Obesity Prospect
10 Sep 2025 //
BIOSPACE
Horizon`s Biologics Tepezza Receives Suppl Approval in US
09 Sep 2025 //
FDA
AMGEN, Kyowa Reveal Phase 3 Rocatinlimab Study Results
09 Sep 2025 //
PR NEWSWIRE
Amgen to Present at Morgan Stanley Global Healthcare Conference
04 Sep 2025 //
PR NEWSWIRE
Amgen-Zai Stomach Cancer Asset Loses OS Benefit in Final Analysis
03 Sep 2025 //
FIERCE BIOTECH
Amgen Invests Over $500M in New Science and Innovation Center
02 Sep 2025 //
PR NEWSWIRE
Amgen Plans $600M R&D Site in California
02 Sep 2025 //
FIERCE BIOTECH
Amgen Enhances Clinical Trials with Veeva Agreement
02 Sep 2025 //
FIERCE BIOTECH
Amgen to Present at The 2025 Wells Fargo Healthcare Conference
30 Aug 2025 //
PR NEWSWIRE
FDA Expands Repatha Use to Adults at Risk of Cardiovascular Event
28 Aug 2025 //
INDPHARMAPOST
Veeva Partners Global Bio to Advance Clinical Trial Innovation
28 Aug 2025 //
PR NEWSWIRE
Horizon’s Biologics Tepezza Receives Suppl Approval in US
26 Aug 2025 //
FDA
BeOne Bags $885 M in Royalty Deal on Amgen`s Imdelltra
26 Aug 2025 //
FIERCE PHARMA
Amgen’s Biologics Avsola Recieves Suppl Approval in US
25 Aug 2025 //
FDA
Amgen Expands Repatha® Use for High Cardiovascular Risk in Adults
25 Aug 2025 //
PR NEWSWIRE
Amgen’s Biologics Repatha Receives Suppl Approval in US
21 Aug 2025 //
FDA
Amgen`s ChemoCentryx Wins Investor Lawsuit
19 Aug 2025 //
FIERCE PHARMA
Amgen Finds Relief in Blincyto Patent Dispute with Lindis
15 Aug 2025 //
FIERCE PHARMA
Judge Overturns Amgen`s $50.3 M Loss in Cancer Drug Patent Case
15 Aug 2025 //
REUTERS
Rare Disease Clinical Progress Boosts Long-Term Revenue Potential
07 Aug 2025 //
PR NEWSWIRE
Amgen Reports Second Quarter 2025 Financial Results
06 Aug 2025 //
PR NEWSWIRE
